Orion Nutraceuticals Inc.

ORI

CA68629J2056

Pharmaceuticals

Delayed Canadian Securities Exchange Other stock markets 07:00:00 21/08/2020 pm IST			5-day change	1st Jan Change
0.4 ^CAD	-.--%		-.--%	-.--%

19/04	Orion Nutraceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	CI
13/03	Joel Dumaresq Resigns as Director of Orion Nutraceuticals Inc	CI

Orion Nutraceuticals Inc. Announces Earnings Results for the First Quarter Ended August 31, 2020

October 31, 2020 at 04:13 am IST

Orion Nutraceuticals Inc. announced earnings results for the first quarter ended August 31, 2020. For the quarter, the company announced net loss was CAD 288,834 compared to CAD 63,889 a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.03 a year ago.

Latest news about Orion Nutraceuticals Inc.

Orion Nutraceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	20/04	CI
Joel Dumaresq Resigns as Director of Orion Nutraceuticals Inc	14/03	CI
Orion Nutraceuticals Inc. Announces Chief Financial Officer Changes	14/03	CI
Orion Nutraceuticals Inc. Announces Chief Executive Officer Changes	14/03	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	20/12	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the First Quarter Ended August 31, 2023	20/23/20	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the Full Year Ended May 31, 2023	29/23/29	CI
Orion Nutraceuticals Inc. Announces the Appointment of Guy Bourgeois and Amanda Boudreau as a Directors	08/23/08	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2023	12/23/12	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2022	05/23/05	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the First Quarter Ended August 31, 2022	19/22/19	CI
Orion Nutraceuticals Inc. Auditor Raises 'Going Concern' Doubt	29/22/29	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the Full Year Ended May 31, 2022	29/22/29	CI
Orion Nutraceuticals Inc. Announces Resignation of Robin Linden as Director	27/22/27	CI
Orion Nutraceuticals Inc. Announces Resignation of Sam Jenkins as Director	16/22/16	CI
Orion Nutraceuticals Inc., Announces Resignation of Kevin Taylor as Director	15/22/15	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	23/22/23	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2021	25/22/25	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the First Quarter Ended August 31, 2021	02/21/02	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the Full Year Ended May 31, 2021	01/21/01	CI
Orion Nutraceuticals Inc. Auditor Raises 'Going Concern' Doubt	30/21/30	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the Third Quarter Ended February 28, 2021	29/21/29	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the Second Quarter Ended November 30, 2020	29/21/29	CI
Orion Nutraceuticals Inc. Announces Earnings Results for the First Quarter Ended August 31, 2020	31/20/31	CI
Orion Nutraceuticals Inc. Reports Earnings Results for the Full Year Ended May 31, 2020	29/20/29	CI

Chart Orion Nutraceuticals Inc.

Duration

Period

More charts

Company Profile

Orion Nutraceuticals Inc. is a Canada-based company. The Company is primarily focused on re-purposing a United States food and drug administration approved drug to target asthma and chronic obstructive pulmonary disease (COPD).

Sector

Pharmaceuticals

Calendar

26/09/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
ORION NUTRACEUTICALS INC.	-.--%	8.68M
DONG-E-E-JIAO CO.,LTD.	+39.90%	6.01B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-22.06%	4.11B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+10.94%	3.28B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.63%	2.83B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-9.17%	2.31B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+44.13%	1.9B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-5.16%	1.55B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+52.16%	1.51B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-16.04%	1.49B